Vivorte, founded in 2008 and based in Louisville, Kentucky, specializes in designing and manufacturing orthopedic devices and bone graft substitutes. The company's core mission is to innovate minimally invasive solutions to reduce hip fractures and enhance bone healing. Vivorte's product lineup includes Trabexus®, a self-setting bone matrix with engineered bone particles for optimal compressive strength and resorptive characteristics, and Fortera®, which combines high compressive strength with superior flow characteristics.
Notable individuals affiliated with Vivorte include experienced professionals in the orthopedic and medical device industry. The company has attracted significant investment from key players in the healthcare sector. Vivorte's achievements include the successful development and market introduction of its proprietary bone graft substitutes, which have positively impacted patient outcomes in orthopedic surgeries. Through its innovative products, Vivorte has established itself as a significant contributor to advancements in orthopedic care.
